These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 46221)

  • 1. Medical treatment of prostatic obstruction. An objective assessment.
    Claridge M
    Invest Urol; 1975 Mar; 12(5):401-4. PubMed ID: 46221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urethral resistance and bladder contractility].
    Susset J
    Ann Urol (Paris); 1993; 27(5):280-3. PubMed ID: 7508214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of Robaveron tablet (KN-7) on urinary disturbance by benign prostatic hypertrophy].
    Sonoda T; Endo H; Maru A; Sasaki K; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1985 Mar; 31(3):553-62. PubMed ID: 2411118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Categorization of obstruction using noninvasive pressure flow measurements: sensitivity to change following prostatectomy.
    Sajeel M; Harding C; Robson W; Drinnan M; Griffiths C; Pickard R
    J Urol; 2007 Sep; 178(3 Pt 1):996-1000; discussion 1000-1. PubMed ID: 17632154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelized analysis of pressure-flow studies of patients with lower urinary tract symptoms due to benign prostatic enlargement.
    Valentini FA; Zimmern PE; Besson GR; Nelson PP
    Neurourol Urodyn; 2003; 22(1):45-53. PubMed ID: 12478601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Micturition complaints in older men].
    Delaere KP
    Tijdschr Gerontol Geriatr; 1986 Feb; 17(1):3-7. PubMed ID: 2420044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of urination disorders with Raveron].
    Ichim V
    Z Urol Nephrol; 1970 Apr; 63(4):255-60. PubMed ID: 4109019
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effects of beta-sitosterol (phytosterol) on benign prostatic hyperplasia: preliminary study].
    Kobayashi Y; Sugaya Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):865-8. PubMed ID: 10028431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy.
    Javlé P; Jenkins SA; Machin DG; Parsons KF
    J Urol; 1998 Nov; 160(5):1713-7. PubMed ID: 9783938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement.
    Drake MJ; Mills IW; Noble JG
    J Urol; 2004 Mar; 171(3):1199-202. PubMed ID: 14767300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of cervico-prostatic obstruction by endoscopic incision of the prostate. Apropos of 16 patients].
    Zerbib M; Antiphon P; Boccon-Gibod
    Ann Urol (Paris); 1986; 20(5):345-8. PubMed ID: 2430501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary flow rate in benign prostatic hypertrophy.
    Anikwe RM
    Int Surg; 1976 Feb; 61(2):109-11. PubMed ID: 56317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.